We are live on ! Find out more
NUVB icon

Nuvation Bio
NUVB

231 hedge funds and large institutions have $947M invested in Nuvation Bio in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 58

45% more call options, than puts

Call options by funds: $5.27M | Put options by funds: $3.64M

27% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 37

4% more funds holding

Funds holding: 223 → 231 (+8)

1.92% more ownership

Funds ownership: 61.7% → 63.62% (+1.9%)

44% less funds holding in top 10

Funds holding in top 10: 9 → 5 (-4)

50% less capital invested

Capital invested by funds: $1.89B → $947M (-$948M)

Holders
231
Holders Change
+8
Holders Change %
+3.59%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.06%
New
47
Increased
90
Reduced
58
Closed
37
Calls
$5.27M
Puts
$3.64M
Net Calls
+$1.63M
Net Calls Change
-$24.5M

Top Buyers

1
DFO
Duquesne Family Office
New York
+$25.3M
2
American Century Companies
American Century Companies
Missouri
+$15.9M
3
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
4
Citadel Advisors
Citadel Advisors
Florida
+$10.8M
5
AG
Algert Global
California
+$8.64M

Top Sellers

1
CFM
Capricorn Fund Managers
United Kingdom
-$14.2M
2
ACM
Abrams Capital Management
Massachusetts
-$14.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$13.4M
4
N
Nuveen
North Carolina
-$13M
5
SCP
SymBiosis Capital Partners
Arkansas
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
76
ExodusPoint Capital Management
New York
$702K +$576K +103,379 +171%
KCM
77
Kornitzer Capital Management
Kansas
$634K +$824K +147,875 New
Susquehanna International Group
78
Susquehanna International Group
Pennsylvania
$616K +$712K +127,751 +805%
VAM
79
Vanguard Asset Management
$616K +$800K +143,580 New
EGM
80
Engineers Gate Manager
New York
$611K +$793K +142,362 New
QCM
81
Quantinno Capital Management
New York
$597K +$547K +98,158 +239%
MWM
82
Meridian Wealth Management
Kentucky
$571K +$109K +19,500 +17%
MIM
83
MetLife Investment Management
New Jersey
$549K -$57.2K -10,266 -7%
Squarepoint
84
Squarepoint
New York
$536K +$696K +124,944 New
VGA
85
Vanguard Global Advisers
Pennsylvania
$528K +$686K +123,162 New
CAM
86
Cresset Asset Management
Illinois
$519K +$13.4K +2,400 +2%
WC
87
Wexford Capital
Florida
$519K -$50.8K -9,111 -7%
ACM
88
Aquatic Capital Management
Illinois
$512K +$664K +119,253 New
Franklin Resources
89
Franklin Resources
California
$509K +$660K +118,409 +64,353%
Barclays
90
Barclays
United Kingdom
$491K -$1.81M -324,781 -74%
Mirae Asset Global ETFs Holdings
91
Mirae Asset Global ETFs Holdings
Hong Kong
$485K +$5.46K +980 +0.9%
Capstone Investment Advisors
92
Capstone Investment Advisors
New York
$481K +$546K +98,018 +693%
Janus Henderson Group
93
Janus Henderson Group
United Kingdom
$463K – – –
WAP
94
Wealthcare Advisory Partners
Pennsylvania
$459K +$262 +47 +0%
Carson Wealth (CWM LLC)
95
Carson Wealth (CWM LLC)
Nebraska
$457K +$22.7K +4,066 +4%
HSA
96
Hussman Strategic Advisors
Maryland
$450K +$585K +105,000 New
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$449K -$970K -174,149 -62%
Marshall Wace
98
Marshall Wace
United Kingdom
$444K -$6.3M -1,130,727 -92%
Creative Planning
99
Creative Planning
Kansas
$435K -$35K -6,290 -6%
PWM
100
Palumbo Wealth Management
New York
$433K -$350K -62,793 -38%
2 3
4
5 6

NUVB Hedge Fund Activity: Q1 2026 in Review

231 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q1 2026, worth a combined $947M — down 50% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new NUVB positions and 37 closed out — a net gain of 10 holders — while 90 added to existing stakes and 58 trimmed.

The largest buyer was Duquesne Family Office, opening a new position worth an estimated $25.3M. The largest seller was Capricorn Fund Managers, exiting entirely with an estimated $14.2M sold.

  • 231 institutional investors held Nuvation Bio (NUVB) as of Q1 2026, up from 223 in Q4 2025.
  • Funds reported $947M of Nuvation Bio stock for Q1 2026, down 50% quarter-over-quarter.
  • 47 funds opened new Nuvation Bio positions in Q1 2026 and 37 closed out, a net change of +10 holders.
  • The largest Nuvation Bio buyer in Q1 2026 was Duquesne Family Office, an estimated $25.3M added.
  • The largest Nuvation Bio seller in Q1 2026 was Capricorn Fund Managers, an estimated $14.2M sold.

Based on aggregated 13F filings for Q1 2026.